David A. Fullerton

University of Colorado Anschutz Medical Campus

Papers

1

Total Citations

14

H-Index

1

About

David A. Fullerton is a leading figure in cardiothoracic surgery, with a research focus on optimizing surgical outcomes for lung cancer patients through minimally invasive techniques. His major contributions center on the adoption and impact of robotic surgery, demonstrating that its introduction significantly increases the rate of segmentectomy—a lung-sparing procedure that preserves healthy tissue—for early-stage non-small cell lung cancer. This work, published in 2021 and already garnering 14 citations, highlights how technological innovation can shift clinical practice toward more patient-friendly, parenchyma-sparing resections, particularly benefiting those with limited pulmonary reserve. Fullerton’s research bridges surgical technique and patient-centered outcomes, advocating for precision in oncologic care. His notable achievements include advancing the evidence base for robotic segmentectomy, a procedure that balances cancer clearance with quality of life. For students and researchers, Fullerton’s work exemplifies how surgical innovation can reshape treatment paradigms, making him a pivotal voice in the evolution of thoracic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Introduction of robotic surgery leads to increased rate of segmentectomy in patients with lung cancer
14 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: University of Colorado Anschutz Medical Campus

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago